Trial Profile
Comparison of 2 different antithymocyte globulin doses for the prevention of GVHD in patients undergoing allogeneic stem cell transplant
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2013
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 30 Dec 2013 New trial record
- 10 Dec 2013 Results presented at the 55th Annual Meeting and Exposition of the American Society of Hematology.